Watchlist Price Alert

Acceleron Pharma Inc. (XLRN)

NASDAQ: XLRN · Real-Time Price · USD

178.75

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	112.76M	101.13M	112.94M	92.52M	106M	87.64M	75.56M	73.99M	38.47M	37.52M	13.54M	13.99M	13.88M	13.64M	13.01M	13.48M	13.14M	13.14M	13.27M	27.77M	28.2M	29.35M	31.88M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	112.76M	101.13M	112.94M	92.52M	106M	87.64M	75.56M	73.99M	38.47M	37.52M	13.54M	13.99M	13.88M	13.64M	13.01M	13.48M	13.14M	13.14M	13.27M	27.77M	28.2M	29.35M	31.88M
Operating Income	-255.49M	-224.09M	-179.34M	-167.31M	-135.29M	-144.99M	-147.21M	-136.44M	-147.67M	-128.81M	-137.58M	-124.41M	-116.25M	-111.76M	-111.77M	-109.98M	-103.33M	-98.26M	-88.01M	-66.11M	-62.23M	-56.34M	-49.78M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.5M	2.91M	4.26M	5.57M	5.15M	4.24M	3.36M	2.55M	1.98M	2M	2.02M	1.85M	1.5M	1.13M	783K
Pretax Income	-254.83M	-223.62M	-178.55M	-166.01M	-132.18M	-138.35M	-137.81M	-124.92M	-136.11M	-119.7M	-130.72M	-118.9M	-111.99M	-108.5M	-109.23M	-108.42M	-99.8M	-95.1M	-87.45M	-56.99M	-64.83M	-55.9M	-44.26M
Net Income	-254.85M	-223.63M	-178.56M	-166.03M	-132.21M	-138.33M	-137.75M	-124.86M	-136.02M	-119.63M	-130.71M	-118.87M	-112.06M	-108.54M	-109.27M	-108.45M	-99.82M	-95.14M	-87.48M	-57.01M	-64.81M	-55.9M	-44.26M
Selling & General & Admin	137.85M	113.78M	98.72M	85.92M	75.8M	70.26M	63.88M	56.44M	51.1M	44.25M	37.87M	34.5M	30.75M	29.64M	33.35M	33.74M	33.01M	31.89M	27.23M	25.3M	24.81M	23.83M	21.78M
Research & Development	230.4M	211.43M	193.55M	173.91M	165.49M	162.37M	158.89M	153.99M	135.04M	122.08M	113.25M	103.91M	99.37M	95.76M	91.43M	89.72M	83.47M	79.52M	74.06M	68.57M	65.63M	61.86M	59.87M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	368.25M	325.21M	292.28M	259.83M	241.29M	232.63M	222.77M	210.44M	186.14M	166.33M	151.12M	138.41M	130.13M	125.4M	124.77M	123.47M	116.48M	111.4M	101.28M	93.88M	90.44M	85.69M	81.66M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	368.25M	325.21M	292.28M	259.83M	241.29M	232.63M	222.77M	210.44M	186.14M	166.33M	151.12M	138.41M	130.13M	125.4M	124.77M	123.47M	116.48M	111.4M	101.28M	93.88M	90.44M	85.69M	81.66M
Income Tax Expense	18K	14K	10K	20K	26K	-19K	-67K	-62K	-94K	-72K	-17K	-27K	70K	41K	36K	32K	15K	36K	-2.33M	6.68M	-2.33M	445K	5.52M
Shares Outstanding (Basic)	60.94M	60.72M	60.58M	60.27M	59.64M	53.86M	53.36M	53.09M	52.88M	52.69M	51.13M	46.23M	46.05M	45.79M	45.52M	45.22M	39.36M	38.63M	38.4M	37.91M	37.62M	37.27M	36.91M
Shares Outstanding (Diluted)	60.94M	60.72M	60.58M	60.27M	59.64M	53.86M	53.36M	53.09M	52.88M	52.69M	51.13M	46.23M	46.05M	45.79M	45.52M	45.22M	39.36M	38.63M	38.4M	37.91M	37.62M	37.27M	38.67M
EPS (Basic)	-4.21	-3.71	-3	-2.9	-2.39	-2.59	-2.59	-2.38	-2.69	-2.46	-2.75	-2.59	-2.46	-2.48	-2.62	-2.7	-2.59	-2.49	-2.31	-1.51	-1.81	-1.62	-1.35
EPS (Diluted)	-4.21	-3.71	-3	-2.9	-2.39	-2.59	-2.59	-2.38	-2.69	-2.46	-2.75	-2.59	-2.46	-2.48	-2.62	-2.7	-2.59	-2.49	-2.31	-1.52	-1.82	-1.63	-1.36
EBITDA	-250.61M	-219.65M	-174.68M	-162.16M	-128.33M	-134.42M	-135.04M	-120.98M	-132.3M	-115.88M	-125.71M	-115.15M	-108.32M	-105.03M	-106.04M	-105.6M	-97.26M	-92.91M	-85.56M	-55.31M	-63.36M	-54.58M	-43.05M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	4.23M	3.97M	3.88M	3.85M	3.85M	3.94M	2.77M	3.94M	3.81M	3.82M	5.01M	3.75M	3.67M	3.47M	3.19M	2.83M	2.54M	2.19M	1.89M	1.68M	1.46M	1.32M	1.21M